November 2014

Intervention and Platform

My team is pursuing multiple therapeutic modalities, including therapies using FDA-approved drugs (drug repurposing), combination therapies, new small molecules, and stem cell-based therapy combined with... Read More

Combination therapy

My team’s new initiative is to develop a “combination therapy” for Wolfram and Type 1 diabetes. What is a “combination therapy”? It is a therapy... Read More


We have identified a few small molecules (i.e., drugs) that can potentially delay the progression of Wolfram syndrome. Our current focus is to make sure... Read More